Big 3 wholesalers to rise with generics; Indian plant shut for polluting;

> Big three drug wholesalers McKesson, Cardinal Health and AmerisourceBergen all are expected to enjoy steep paydays as a result of the coming generic boom. Story

> A pollution control board in India has shut down an Orchid Chemicals & Pharmaceuticals cephalosporin API manufacturing plant for solid waste disposal violations. News

> Phillips Plastics will acquire Medisize, a European provider of design and manufacturing services to pharma, diagnostic and medical device companies. Item

> In Nigeria, the health ministry secretary has challenged pharmaceutical companies to upgrade their facilities and processes to be in line with those required for World Health Organization prequalification. Article

> Developments in nanotechnology and electronic printing are being used to fight counterfeits. Story

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.